| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Renato Elias Moreira Júnior, Agatha Sondertoft Braga Pedersen, Raquel Mary Ferreira, Guilherme Henrique de Asevedo, Grazielle Laudares Mendes, Karine Ribeiro, Tatiani Uceli Maioli, Ana Maria Caetano de Faria, Ana Lúcia Brunialti-Godar. Behavioral changes and transcriptional regulation of mesolimbic dopaminergic genes in a mouse model of binge eating disorder by diet intermittent access. The Journal of nutritional biochemistry. 2024-10-19. PMID:39426552. |
behavioral changes and transcriptional regulation of mesolimbic dopaminergic genes in a mouse model of binge eating disorder by diet intermittent access. |
2024-10-19 |
2024-10-22 |
mouse |
| Paula Trujillo, Alexander K Song, Kaitlyn R Hay, Megan Aumann, Yan Yan, Hakmook Kang, Manus J Donahue, Daniel O Claasse. Dopamine-induced changes to thalamic GABA concentration in impulsive Parkinson disease patients. NPJ Parkinson's disease. vol 8. issue 1. 2022-04-06. PMID:35383185. |
in parkinson disease (pd), dopaminergic therapies can result in the development of impulsive and compulsive behaviors, and this clinical syndrome shares similar pathophysiology to that seen in addiction, substance abuse, and binge-eating disorders. |
2022-04-06 |
2023-08-13 |
Not clear |
| Brandon A Heidinger, Jameason D Cameron, Regis Vaillancourt, Michael De Lisio, Matthew Ngu, Giorgio A Tasca, Livia Chyurlia, Éric Doucet, Steve Doucette, Ana Maria Obregón Rivas, Gary S Goldfiel. No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder. Gene. vol 781. 2021-04-05. PMID:33631245. |
no association between dopaminergic polymorphisms and response to treatment of binge-eating disorder. |
2021-04-05 |
2023-08-13 |
Not clear |
| Brandon A Heidinger, Jameason D Cameron, Regis Vaillancourt, Michael De Lisio, Matthew Ngu, Giorgio A Tasca, Livia Chyurlia, Éric Doucet, Steve Doucette, Ana Maria Obregón Rivas, Gary S Goldfiel. No association between dopaminergic polymorphisms and response to treatment of binge-eating disorder. Gene. vol 781. 2021-04-05. PMID:33631245. |
the genetics of binge-eating disorder (bed) is an emerging topic, with dopaminergic genes being implicated in its etiology due to the role that dopamine (da) plays in food reward sensitivity and self-regulation of eating behavior. |
2021-04-05 |
2023-08-13 |
Not clear |
| David J Heal, Michelle Hallam, Michael Prow, Jane Gosden, Sharon Cheetham, Yong K Choi, Frank Tarazi, Peter Hutso. Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder. Journal of psychopharmacology (Oxford, England). vol 31. issue 6. 2018-03-22. PMID:28376679. |
we investigated whether (a) dysregulated central nervous system dopaminergic and opioidergic systems are part of the psychopathology of binge-eating and (b) these neurotransmitter systems may mediate the actions of drugs ameliorating binge-eating disorder psychopathology. |
2018-03-22 |
2023-08-13 |
rat |
| Chloe Luck, Martha H Vitaterna, Rachel Wevric. Dopamine pathway imbalance in mice lacking Magel2, a Prader-Willi syndrome candidate gene. Behavioral neuroscience. vol 130. issue 4. 2017-11-16. PMID:27254754. |
our results provide a biological framework for clinical studies of dopaminergic function in children with prader-willi syndrome, and may also provide insight into binge-eating disorders that occur in the general population. |
2017-11-16 |
2023-08-13 |
mouse |
| Hirotomo Nakaoka, Masaki Mogi, Harumi Kan-No, Kana Tsukuda, Kousei Ohshima, Xiao-Li Wang, Toshiyuki Chisaka, Hui-Yu Bai, Bao-Shuai Shan, Masayoshi Kukida, Jun Iwanami, Masatsugu Horiuch. Angiotensin II type 2 receptor signaling affects dopamine levels in the brain and prevents binge eating disorder. Journal of the renin-angiotensin-aldosterone system : JRAAS. vol 16. issue 4. 2016-09-30. PMID:25757658. |
binge eating disorder (bed) is associated with dopaminergic activation as food reward, resulting in metabolism-related disorders. |
2016-09-30 |
2023-08-13 |
Not clear |
| F Depierreux-Lahaye, J Crémers, E Skawiniak, E Parmentier, V Delvaux, G Garrau. [Impulse control behaviors associated with antiparkinsonian medications]. Revue medicale de Liege. vol 68. issue 5-6. 2013-08-27. PMID:23888568. |
in some patients, impulse control behaviours can be triggered by dopaminergic replacement therapy, particularly dopamine agonist drugs: hobbyism, punding (stereotyped behaviours), compulsive buying, binge eating disorder, pathological gamgling, hypersexuality, hedonistic homeostatic dysregulation syndrome ... |
2013-08-27 |
2023-08-12 |
Not clear |
| Muhammad U Farooq, Philip W Moore, Archit Bhatt, Rany Aburashed, Mounzer Y Kassa. Therapeutic role of zonisamide in neuropsychiatric disorders. Mini reviews in medicinal chemistry. vol 8. issue 10. 2008-11-17. PMID:18782051. |
its activity is related to the blockade of voltage gated sodium and calcium channels, modulation of central dopaminergic, gabaergic, and serotonergic functions, as well as inhibition of carbonic anhydrase and monoamine oxidase b. zns has potential efficacy for an array of neuropsychiatric disorders including migraine and other headache syndromes, neuropathic pain, parkinson's disease, essential tremor, stroke, obesity, anxiety, bipolar and binge-eating disorders. |
2008-11-17 |
2023-08-12 |
Not clear |